Gierthmühlen, Janne
Binder, Andreas
Baron, Ralf
Article History
First Online: 19 August 2014
Competing interests
: J.G. has received honoraria from Grünenthal and Pfizer. A.B. has received honoraria from Astellas, Allergan, Bayer, Boehringer-Ingelheim, Grünenthal and Pfizer and participated in the advisory boards of Astellas, Boehringer-Ingelheim, Genzyme, and Grünenthal. R.B. has received grant/research support from Pfizer, Genzyme and Grünenthal. He is a member of the IMI EuroPain collaboration, in which the following industry members are represented: Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Esteve, Grünenthal, Pfizer, UCB-Pharma and Sanofi Aventis. He has received honoraria as a speaker from Astellas, Bayer-Schering, Boehringer Ingelheim, Desitin, Eisai, Eli Lilly, Genzyme, Grünenthal, Medtronic, Mundipharma, MSD, Pfizer, Sanofi Pasteur and Teva Pharma. He is also a consultant for Abbvie, Allergan, Astellas, AstraZeneca, Biogen Idec, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Eli Lilly, Genzyme, Grünenthal, Medtronic, Merck, Mundipharma, Novartis, Pfizer and Sanofi Pasteur.